104 related articles for article (PubMed ID: 48414)
1. Virologic and immunologic studies of human prostatic carcinoma.
Dmochowski L; Maruyama K; Ohtsuki Y; Seman G; Bowen JM; Newton WA; Johnson DE
Cancer Chemother Rep; 1975; 59(1):17-31. PubMed ID: 48414
[TBL] [Abstract][Full Text] [Related]
2. Search for oncogenic viruses in human prostate cancer.
Dmochowski L; Ohtsuki Y; Seman G; Maruyama K; Knesek JE; East JL; Bowen JM; Yoshida H; Johnson DE
Cancer Treat Rep; 1977; 61(2):119-27. PubMed ID: 68817
[TBL] [Abstract][Full Text] [Related]
3. Morphologic and immunologic studies of human prostatic carcinoma.
Mickey DD; Stone KR; Stone MP; Paulson DF
Cancer Treat Rep; 1977; 61(2):133-8. PubMed ID: 68819
[TBL] [Abstract][Full Text] [Related]
4. Role of oncornaviruses in carcinoma of the prostate.
McCombs RM
Cancer Treat Rep; 1977; 61(2):131-2. PubMed ID: 68818
[TBL] [Abstract][Full Text] [Related]
5. Ultrastructural studies of human prostatic neoplasia.
Ohtsuki Y; Seman G; Maruyama K; Bowen JM; Johnson DE; Dmochowski L
Cancer; 1976 May; 37(5):2295-305. PubMed ID: 56984
[TBL] [Abstract][Full Text] [Related]
6. Human prostatic tumor cells in culture produce growth and differentiation factors active on osteoblasts: a new biological and clinical parameter for prostatic carcinoma.
Festuccia C; Teti A; Bianco P; Guerra F; Vicentini C; Tennina R; Villanova I; Sciortino G; Bologna M
Oncol Res; 1997; 9(8):419-31. PubMed ID: 9436195
[TBL] [Abstract][Full Text] [Related]
7. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.
Purnell DM; Heatfield BM; Trump BF
Cancer Res; 1984 Jan; 44(1):285-92. PubMed ID: 6197163
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator activities in short-term tissue cultures of benign prostatic hyperplasia and prostatic carcinoma.
Festuccia C; Vincentini C; di Pasquale AB; Aceto G; Zazzeroni F; Miano L; Bologna M
Oncol Res; 1995; 7(3-4):131-8. PubMed ID: 8555646
[TBL] [Abstract][Full Text] [Related]
9. Expression of the VEGF-receptor Flt-1 in benign, premalignant and malignant prostate tissues.
Hahn D; Simak R; Steiner GE; Handisurya A; Susani M; Marberger M
J Urol; 2000 Aug; 164(2):506-10. PubMed ID: 10893635
[TBL] [Abstract][Full Text] [Related]
10. Increased matrix metalloproteinase-9 secretion in short-term tissue cultures of prostatic tumor cells.
Festuccia C; Bologna M; Vicentini C; Tacconelli A; Miano R; Violini S; Mackay AR
Int J Cancer; 1996 Oct; 69(5):386-93. PubMed ID: 8900372
[TBL] [Abstract][Full Text] [Related]
11. Cathepsin B in angiogenesis of human prostate: an immunohistochemical and immunoelectron microscopic analysis.
Sinha AA; Gleason DF; Staley NA; Wilson MJ; Sameni M; Sloane BF
Anat Rec; 1995 Mar; 241(3):353-62. PubMed ID: 7538734
[TBL] [Abstract][Full Text] [Related]
12. FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasia.
Polnaszek N; Kwabi-Addo B; Wang J; Ittmann M
Prostate; 2004 Jun; 60(1):18-24. PubMed ID: 15129425
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D receptor, HER-2 polymorphisms and risk of prostate cancer in men with benign prostate hyperplasia.
Tayeb MT; Clark C; Haites NE; Sharp L; Murray GI; McLeod HL
Saudi Med J; 2004 Apr; 25(4):447-51. PubMed ID: 15083213
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro.
Okamoto M; Lee C; Oyasu R
Cancer Res; 1997 Jan; 57(1):141-6. PubMed ID: 8988055
[TBL] [Abstract][Full Text] [Related]
15. Lack of immunohistochemical detection of VEGF in prostate carcinoma.
Kamath A; Helie M; Bifulco CB; Li WW; Concato J; Jain D
Appl Immunohistochem Mol Morphol; 2009 May; 17(3):227-32. PubMed ID: 19098681
[TBL] [Abstract][Full Text] [Related]
16. Interferon-gamma and its functional receptors overexpression in benign prostatic hyperplasia and prostatic carcinoma: parallelism with c-myc and p53 expression.
Royuela M; de Miguel MP; Ruiz A; Fraile B; Arenas MI; Romo E; Paniagua R
Eur Cytokine Netw; 2000 Mar; 11(1):119-27. PubMed ID: 10705309
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples.
Gravina GL; Mancini A; Ranieri G; Di Pasquale B; Marampon F; Di Clemente L; Ricevuto E; Festuccia C
Int J Oncol; 2013 Jun; 42(6):2116-22. PubMed ID: 23589051
[TBL] [Abstract][Full Text] [Related]
18. Do men with prostate abnormalities (prostatitis/benign prostatic hyperplasia/prostate cancer) develop immunity to spermatozoa or seminal plasma?
Hoover P; Naz RK
Int J Androl; 2012 Aug; 35(4):608-15. PubMed ID: 22321000
[TBL] [Abstract][Full Text] [Related]
19. Expression of somatostatin receptor subtypes 2 and 4 in human benign prostatic hyperplasia and prostatic cancer.
Hansson J; Bjartell A; Gadaleanu V; Dizeyi N; Abrahamsson PA
Prostate; 2002 Sep; 53(1):50-9. PubMed ID: 12210479
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia.
Theyer G; Kramer G; Assmann I; Sherwood E; Preinfalk W; Marberger M; Zechner O; Steiner GE
Lab Invest; 1992 Jan; 66(1):96-107. PubMed ID: 1370561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
